The Medigene Share
The Medigene share MDG1 (ISIN:DE000A1X3W00 ) is listed at the Frankfurt Stock Exchange since June 2000.
Investors & Media
Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and key figures.
Latest News
Medigene publication details augmentation of PRAME-specific TCR-4 by PD1-41BB switch receptor
Events
03
Aug 2022
6-Months Report 2022
07 - 08
Sep 2022
Stifel London Cross Sector Insight Conference
19 - 21
Sep 2022
Berenberg and Goldman Sachs 11th German Corporate Conference
02
Nov 2022
Quarterly Statement Q3 2022
Corporate Governance
Good corporate governance is the basis of our decision-making and monitoring processes. It stands for responsible and value-based leadership and control of the Company for long-term success, goal-oriented and efficient cooperation between the Executive Board and Supervisory Board, respect for the interests of our shareholders and employees, consistently transparent and responsible corporate decisions and an appropriate risk management system.
Contact person
Dr. Anna Niedl
Vice President Investor Relations & Corporate Communications
investor(at)medigene.com
Phone: +49 89 2000 3333 01
Fax: +49 89 2000 33 2920